CABYC
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Alemtuzumab Use (MabCampath®) in Hematopoietic Transplant of Unrelated Donor With Reduced Intensity Conditioni Graft Versus Host Disease | Phase 2 | 2008-07-01 |
| Withdrawn | R-CHOP and Alemtuzumab in Patients With Chronic Lymphocytic Leukemia Chronic Lymphocytic Leukaemia, Patients Resistant to a Purine Analogous, Patients Relapsed With Purines Therapy | Phase 2 | 2007-07-01 |
| Completed | Safety Study to Evaluate Induction and Consolidation Treatment in Patients With Mantle Cell Lymphoma (LCM-04-0 Mantle Cell Lymphoma | Phase 2 | 2006-01-01 |